ArticlePLOS digital health2026
Reliability of a convolutional neural network in segmenting multiple sclerosis lesions from MRI: Impact of data augmentation, image modality and tolerance with U-Net architecture.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system, typically exhibiting radiologically identifiable lesions within the brain and spinal cord, features key to both diagnosis and clinical disease monitoring. Manually identifying and segmenting lesions is both difficult and time consuming, thus optimising approaches to reliably automate segmentation is highly beneficial. The aim of this study was to assess the impact of data augmentation and manipulation on the accuracy of automated lesion segmentation using MRI scans from MS patients. Factors examined include MRI modalities in both isolation and combination, image augmentation, lesion size and size of testing set relative to training. The MICCAI 2016 MS dataset was used in this study, with U-Net chosen as the algorithmic method for segmentation. Each factor was optimised and then combined to maximise segmentation accuracy; the Dice metric was used as the focal metric to assess the efficacy of any given permutation of the setup. Statistical significance was assessed using the Mann-Whitney U-test, with each permutation repeated five to ten times to ensure robustness. The best Dice score achieved using the testing and training dataset as outlined in the MICCAI 2016 challenge rubric was 0.59, approximately a 2% improvement against controls. To achieve this result whilst adhering to the training and testing distribution as defined in the dataset publication, the optimal imaging sequence was determined to be proton density. The augmentation conditions used included implementing an additional rotation of the dataset (doubling it in size) and excluding lesions < 36.43 mm3 in volume. The impact of data manipulation and augmentation was found to be statistically significant against controls using a Mann-Whitney U-test for lesion segmentation. An ancillary finding of this study was that there was no statistically significant difference between using one MRI modality for training and another for testing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.